Youngevity Enters Cannabis Market with Hemp FX™ Product Line

YGYI, Inc. (YGYI), a leading omni-direct lifestyle company, introduced their new Hemp FX™ product line at their 2018 Convention in San Diego, Calif. These cannabis products are comprised of three new proprietary blends of hemp-derived cannabinoid products (Soothe™, Relax™, and Uplift™).  A limited quantity of the three new formulas was available for Pre- Sale purchase to attendees at Youngevity’s Convention and quickly sold-out at the event.  Youngevity’s Hemp FX™ products will be available for purchase to the public soon with the official launch date to take place by October 2018.

To be alerted and notified about the upcoming official launch and to learn more about Youngevity’s Hemp FX product line, visit hempfx.com.

Newcomer to Cannabis

Youngevity gets into $7.7 billion Cannabis market
Youngevity introduces Hemp FX™ Product Line

For 21 years, Youngevity has prided itself on developing the highest-quality and most well-researched nutritional products. Each formula in the Hemp FX product line combines an exclusive source of organically grown hemp-derived cannabinoids (cannabis) with Youngevity signature nutrients.

 

Soothe™

contains a proprietary hemp-derived cannabinoid oil, as well as a variety of herbs, minerals, and a powerful antioxidant – glutathione.  Soothe™ supports a healthy immune system and soothes sore, tired, and achy muscles and joints.

Relax™

features the same hemp-derived cannabinoid oil found in Soothe™, combined with the relaxing botanicals chamomile, lavender, valerian, and melatonin –for its sleep-supporting benefits.

Uplift™

takes Youngevity’s exclusive hemp-derived cannabinoid oil and combines it with St. John’s Wort and a specialized set of natural terpenes (cannabinoid enhancers).

The cannabidiol market is expected to see significant growth in the immediate future. Direct Selling News recently reported that “According to recent data published by Forbes, citing Brightfield Group, the global cannabis market is projected to reach $31.4 billion by 2021. By end of 2017, the global market value was estimated at $7.7 billion.”

With validation from independent 3rd party testing and the growing market, the (cannabis) Hemp FX products have the capacity to transform the nutritional industry and Youngevity’s consumer base. Youngevity CEO, Steve Wallach states,

“Hemp-derived cannabidiol aligns with what we do very well. We’ve taken what we know about essential nutrients, along with decades of knowledge specializing in natural, plant-based nutrition and their most beneficial nutrients and put that knowledge to work to develop high-end cannabidiol products.”

 

 

 

 

Disclaimer: Kevin Surbaugh distributes Youngevity (YGYI) as an independent sales representative and invests in the publicly traded company.
He also has positions in Coca-Cola (KO), Berkshire-Hathaway (BRK.B); (BRK.A), and WalMart (WMT), but has no positions in any other stocks mentioned, and no plans to initiate any positions within the next 96 hours.

Leave a Reply

Your email address will not be published. Required fields are marked *